GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant |
| February 14, 2018 | February 2018 Bond Updates |
|
YONGIN, South Korea, Feb. 13, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, and Lee's Pharmaceutical (HK) Limited, a wholly-owned subsidiary of Lee's Pharmaceutical Holdings Limited ("Lee's Pharm")... |
| View more at: https://www.prnewswire.com/news-releases/gc-pharma-and-lees-pharm-enter-into-china-licensing-agreement-to-develop-and-commercialise-gcc-4401c-an-investigational-anticoagulant-300598462.html |
| Related News |